SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-24-002333
Filing Date
2024-01-29
Accepted
2024-01-29 14:07:33
Documents
1
Period of Report
2024-01-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3963
  Complete submission text file 0001209191-24-002333.txt   5665
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Issuer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address C/O POINT BIOPHARMA GLOBAL INC. 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address
Martell Bridget A (Reporting) CIK: 0001629627 (see all company filings)

Type: 4 | Act: 34 | File No.: 033-80623 | Film No.: 24572698